Ameritas Investment Partners’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Ameritas Investment Partners’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-269	Closed	-$18K	–	3324
2021 Q1	$18K	Buy	269 +121	+82%	+$8.44K	﹤0.01%	2625
2020 Q4	$10K	Hold	148	–	–	﹤0.01%	2805
2020 Q3	$8K	Hold	148	–	–	﹤0.01%	2844
2020 Q2	$14K	Hold	148	–	–	﹤0.01%	2559
2020 Q1	$8K	Hold	148	–	–	﹤0.01%	2662
2019 Q4	$12K	Hold	148	–	–	﹤0.01%	2675
2019 Q3	$13K	Hold	148	–	–	﹤0.01%	2634
2019 Q2	$19K	Hold	148	–	–	﹤0.01%	2488
2019 Q1	$27K	Hold	148	–	–	﹤0.01%	2235
2018 Q4	$16K	Hold	148	–	–	﹤0.01%	2475
2018 Q3	$20K	Hold	148	–	–	﹤0.01%	2522
2018 Q2	$20K	Hold	148	–	–	﹤0.01%	2527
2018 Q1	$20K	Hold	148	–	–	﹤0.01%	2429
2017 Q4	$18K	Hold	148	–	–	﹤0.01%	2497
2017 Q3	$19K	Hold	148	–	–	﹤0.01%	2461
2017 Q2	$26K	Hold	148	–	–	﹤0.01%	2318
2017 Q1	$18K	Buy	+148	New	+$15.4K	﹤0.01%	2477

Other funds holding SRGA

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Ameritas Investment Partners's SRGA Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2021, closing a stake of 269 shares — an estimated $18K sold.

Ameritas Investment Partners first reported a position in SRGA in Q1 2017 and held it in 17 quarters. The position peaked at $27K in Q1 2019. 89 funds tracked by Wall St. Rank hold SRGA as of Q2 2021.

Ameritas Investment Partners reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 269 Surgalign Holdings, Inc. Common Stock shares in Q2 2021, an estimated $18K.
Ameritas Investment Partners first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2017 and held it in 17 quarters.
Ameritas Investment Partners's Surgalign Holdings, Inc. Common Stock position peaked at $27K in Q1 2019.
89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.